Language selection

Search

Patent 2748894 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2748894
(54) English Title: SURGICAL ARTICLES AND METHODS FOR TREATING URINARY INCONTINENCE
(54) French Title: ARTICLES CHIRURGICAUX ET METHODES DE TRAITEMENT DE L'INCONTINENCE URINAIRE
Status: Deemed expired
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61F 2/00 (2006.01)
(72) Inventors :
  • VANDEWEGHE, ANDREW (United States of America)
  • WIRBISKY, ALAN G. (United States of America)
  • LIESER, RANDALL C. (United States of America)
(73) Owners :
  • BOSTON SCIENTIFIC SCIMED, INC. (United States of America)
(71) Applicants :
  • AMS RESEARCH CORPORATION (United States of America)
(74) Agent: SMART & BIGGAR LLP
(74) Associate agent:
(45) Issued: 2018-11-13
(86) PCT Filing Date: 2010-02-10
(87) Open to Public Inspection: 2010-08-09
Examination requested: 2015-01-19
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US2010/000325
(87) International Publication Number: WO2010/093421
(85) National Entry: 2011-07-04

(30) Application Priority Data:
Application No. Country/Territory Date
61/151,378 United States of America 2009-02-10
61/151,550 United States of America 2009-02-11

Abstracts

English Abstract




Described are devices,
implants and kits for treating incontinence
in a male or female. In particular
an assembly comprising a multi-piece
implant comprising a support
portion piece (82) and two extension
portion pieces (84) adjustably connected
to the support portion piece,
and an adjusting tool (92) to allow
adjustment of extension portion
pieces relative to the support portion
piece, is described




French Abstract

La présente invention concerne des dispositifs, des implants, des kits, et des méthodes afférentes, destinées au traitement de l'incontinence chez un homme ou une femme.

Claims

Note: Claims are shown in the official language in which they were submitted.


CLAIMS:
1. An assembly for treating urinary incontinence, the assembly comprising a

multi-piece implant comprising a support portion piece, a first extension
portion piece, and a
second extension portion piece, and an adjusting tool, wherein
the support portion piece comprises a tissue support portion sized and shaped
for placement to support a urethra,
the first and second extension portion pieces each comprise a proximal end, a
distal end, and a tissue fastener,
the first extension portion piece is adjustably connected to the support
portion
piece at a first adjustable connection,
the second extension portion piece is adjustably connected to the support
portion piece at a second adjustable connection, and
the adjusting tool comprises a shaft, a yoke, and two adjusting surfaces
located
at the yoke, wherein the two adjusting surfaces are configured for
simultaneous engagement
with two spaced-apart surfaces of the support portion piece during
simultaneous adjustment of
a position of the first extension portion piece relative to the support
portion piece at the first
adjustable connection and a position of the second extension portion piece
relative to the
support portion piece at the second adjustable connection.
2. An assembly according to claim 1, wherein each of the two adjusting
surfaces
is adjacent to a slot or aperture adapted to engage the extension portion
piece.
3. An assembly according to claim 1, wherein the yoke is stationary
relative to
the shaft.
4. An assembly according to claim 1, wherein the yoke can be moved relative
to a
length of the shaft.
33

5. An implant according to claim 1, wherein the adjustable connection
comprises
an aperture through which the extension portion piece extends to adjustably
connect the
extension portion piece to the support portion piece.
6. An implant according to claim 1, wherein the adjustable connection
comprises
a grommet.
7. An implant according to claim 1, wherein the extension portion piece
comprises a tissue fastener.
8. An implant according to claim 1, wherein the implant comprises
supportive
portions consisting of the tissue support portion and two extension portions.
9. In combination, an implant for treating urinary incontinence and an
adjusting
tool, the implant comprising
a tissue support portion sized and shaped for placement to support a urethra,
and
a first and second extension portion, each extension portion extending from an

end of the tissue support portion, and
a tissue fastener located at a distal end of each extension portion, wherein
each
extension portion comprises an adjustable length between the tissue support
portion and the
tissue fastener the adjusting tool comprising:
two adjusting apertures, a shaft, and a yoke, the two adjusting apertures
located
at a distal end of the yoke and configured for simultaneous engagement with
the first and
second extension portions during simultaneous adjustment of the first and
second extension
portions relative to the tissue support portion, wherein the yoke is axially
movable relative to
a length of the shaft.
34

10. An
implant according to claim 9, wherein each of the two extension portions
comprises a suture, and the tissue fastener is a self-fixating tip adjustably
connected to the
suture.

Description

Note: Descriptions are shown in the official language in which they were submitted.


I I
CA 2748894 2017-04-21
SURGICAL ARTICLES AND METHODS FOR TREATING URINARY
INCONTINENCE
FIELD OF THE INVENTION
The invention relates to apparatus and methods for treating urinary
incontinence by use
of an implant to support urethral tissue.
BACKGROUND
Men, women, and children of all ages can suffer from urinary incontinence or
involuntary
loss of urinary control. Their lives are perpetually interrupted by thoughts
of ensuring that they
have ready access to a restroom. Everyday activities such as attending a
theater or sporting event
can become unpleasant. Sufferers often begin to avoid social situations in an
effort to reduce the
stress associated with their condition.
A variety of treatment options are currently available. Some of these include
external
devices, behavioral therapy (such as biofeedback, electrical stimulation, or
Kegel exercises),
prosthetic devices, and surgery. Depending on the age, medical condition, and
personal
preference of a patient, surgical procedures can be used to completely restore
continence.
One type of surgical procedure found to be an especially successful treatment
option for
incontinence in both men and women, is a sling procedure. Sling procedures
typically entail
surgically implanting a biocompatible implant or "sling" to support the
bladder neck or urethra.
Sling procedures are discussed in U.S. Pat. Nos. 5.112,344; 5,611,515;
5,842,478; 5,860,425;
5,899,909; 6,039,686; 6,042,534; 6,110,101: 6,478,727; 6,638,211; and PCT
Publication Nos.
WO 02/39890 and WO 02/069781.
Some ''pubomedial" sling procedures involve an abdominal incision and
installation of a
sling between the rectus fascia in the abdominal region to a position below
the urethra, and back
again to the rectus fascia. A conventional procedure in females is to
surgically place a sling by
entering the abdominal cavity through an incision in the patient's pubovaginal
region.
In males, one example of a conventional method involves surgical placement of
a sling
by entering the abdominal cavity through an abdominal incision. Unfortunately,
to access the
1

84136979
abdominal cavity a surgeon must incise the male patient's abdominal muscles.
This
procedure is more time consuming and uncomfortable for the male patient.
Other methods for treating pelvic conditions involve installation of a sling
below the
urethra through incisions made at the inner thigh (e.g., in the perineal skin
facing the obturator
and in the groin), and using a tissue path extending through the obturator.
These procedures
can be referred to as "transobturator" methods. See, e.g., U.S. Patent No.
6,911,003 and
Published U.S. Pat. Appl. No. 2003/0171644A1.
While abdominal and transobturator methods of treating urinary incontinence
can be
effective, safe, and long-lasting, there is ongoing effort toward improving
these methods.
SUMMARY
The invention relates to methods of treating urinary incontinence in males and

females.
Certain embodiments comprise an assembly for treating urinary incontinence,
the
assembly comprising a multi-piece implant comprising a support portion piece,
a first
extension portion piece, and a second extension portion piece, and an
adjusting tool, wherein
the support portion piece comprises a tissue support portion sized and shaped
for placement to
support a urethra, the first and second extension portion pieces each comprise
a proximal end,
a distal end, and a tissue fastener, the first extension portion piece is
adjustably connected to
the support portion piece at a first adjustable connection, the second
extension portion piece is
adjustably connected to the support portion piece at a second adjustable
connection, and the
adjusting tool comprises a shaft, a yoke, and two adjusting surfaces located
at the yoke,
wherein the two adjusting surfaces are configured for simultaneous engagement
with two
spaced-apart surfaces of the support portion piece during simultaneous
adjustment of a
position of the first extension portion piece relative to the support portion
piece at the first
adjustable connection and a position of the second extension portion piece
relative to the
support portion piece at the second adjustable connection.
2
CA 2748894 2018-01-09

84136979
Certain embodiments comprise in combination, an implant for treating urinary
incontinence and an adjusting tool, the implant comprising a tissue support
portion sized and
shaped for placement to support a urethra, and a first and second extension
portion, each
extension portion extending from an end of the tissue support portion, and a
tissue fastener
located at a distal end of each extension portion, wherein each extension
portion comprises an
adjustable length between the tissue support portion and the tissue fastener
the adjusting tool
comprising: two adjusting apertures, a shaft, and a yoke, the two adjusting
apertures located at
a distal end of the yoke and configured for simultaneous engagement with the
first and second
extension portions during simultaneous adjustment of the first and second
extension portions
relative to the tissue support portion, wherein the yoke is axially movable
relative to a length
of the shaft.
Certain embodiments of methods and implants involve placement of a tissue
support
portion an implant below a urethra, placement of extension portions of the
implant at tissue
paths that extend from a location to support the urethra in a toward an
obturator foramen. A
tissue path may extend and end at pelvic fascia without reaching or passing
into or through the
obturator foramen. In other embodiments a tissue path may extend to the
obturator foramen.
In still other embodiments the tissue path may extend through an obturator
foramen and to an
external incision at an inner thigh. The methods can involve two opposing
tissue paths, as
described, one on each of a left and a right side of the patient.
2a
CA 2748894 2018-01-09

CA 02748894 2011-07-04
WO 2010/093421 PCT/US2010/000325
The implant may involve adjustable extension portions, and the methods
may involve adjusting the adjustable extension portions. Alternately or in
addition,
the implant may be adjusted by use of an adjusting tool that can contact
spaced-apart
surfaces of an implant to allow contact and manipulation of the two surfaces,
simultaneously, by the single tool.
Other embodiments of implants and methods can alternately or additionally
involve the use of "small-diameter" insertion tools (e.g., needles) that can
be passed
through a tissue path (that traverses the obturator foramen) with reduced
trauma to
the patient.
Still other embodiments of methods of treating incontinence in a male or
female patient can involve the use of a urethra-positioning tool that can
position a
urethra in a location and manner to improve continence, followed by fixing the

urethra in that position.
In one aspect, the invention relates to an assembly for treating urinary
incontinence. The assembly includes a multi-piece implant having a support
portion
piece and two extension portion pieces, and an adjusting tool. The support
portion
piece includes a tissue support portion sized and shaped for placement to
support a
urethra, and the extension portion pieces each include a proximal end, a
distal end,
and a tissue fastener. The first extension portion piece is adjustably
connected to the
support portion piece at a first adjustable connection. The second extension
portion
piece is adjustably connected to the support portion piece at a second
adjustable
connection. The adjusting tool includes two adjusting surfaces, the two
adjusting
surfaces being capable of simultaneously engaging the support portion piece to

allow adjustment of a position of the extension portion piece relative to the
support
portion piece at the first adjustable connection, and adjustment of a position
of the
second extension portion piece relative to the support portion piece at the
second
adjustable connection.
In a related aspect, the assembly can be used to treat urinary incontinence
according to methods that involve: providing the assembly; creating a medial
incision in the patient; dissecting from the medial incision to tissue below a
urethra;
placing the tissue support portion to contact tissue to support the urethra;
placing a
distal end of the first extension portion in a tissue path extending toward a
first
3

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
obturator foramen of the patient; placing a distal end of the second extension
portion
in a tissue path extending toward a second obturator foramen of the patient;
connecting the first extension portion piece with the support portion piece at
the first
adjustable connection; connecting the second extension portion piece with the
support portion piece at the second adjustable connection; engaging the
adjusting
tool with the support portion piece, and adjusting a position of the support
portion
piece relative to first and second extension portion pieces.
In another aspect, the invention relates to an implant for treating urinary
incontinence. The implant includes a tissue support portion sized and shaped
for
placement to support a urethra; two extension portions, each extension portion
extending from an end of the tissue support portion; and a tissue fastener at
each
extension portion. Each extension portion has an adjustable length between the

tissue support portion and the tissue fastener.
In a related aspect the invention relates to a method of treating urinary
incontinence in a patient using this type of implant. The method includes:
providing
the implant; creating a medial incision in the patient; dissecting from the
medial
incision to tissue below a urethra; placing the tissue support portion to
support the
urethra; placing the tissue fastener at the first extension portion in a
tissue path
extending toward a first obturator foramen of the patient; placing the tissue
fastener
at the second extension portion in a tissue path extending toward a second
obturator
foramen of the patient; and adjusting a length of an extension portion.
In another aspect the invention relates to an assembly for treating urinary
incontinence in a patient. The assembly includes an implant comprising a
tissue
support portion and two extension portions, and an insertion tool. The
insertion tool
has a small-diameter needle having a diameter of less than 0.09 inch, a radius
of
curvature at a tip at one end of the needle that is less than 0.015 inch, and
a length to
extend between a medial incision in a patient, and a lateral incision in a
patient
adjacent to an obturator foramen.
In a related aspect, the invention involves method of treating urinary
incontinence, by using this assembly. The method includes: providing the
assembly;
creating a medial incision in the patient; dissecting from the medial incision
to tissue
below a urethra; placing the tissue support portion to support the urethra;
attaching
4

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
the extension portion to the small diameter needle; using the small-diameter
needle,
passing the extension portion between the medial incision and an external
location
adjacent to an obturator foramen, the needle and extension portion passing
through
an obturator foramen.
In another aspect the invention relates to a urethra-positioning tool having
an
elongate shaft capable of being inserted through a meatus and into a urethra
to adjust
a positioning of the urethra.
A related aspect of the invention relates to a method of treating urinary
treating incontinence using the urethra-positioning tool. The method includes:
providing the urethra-positioning tool; inserting the shaft through a meatus
and into
a urethra; using the urethra-positioning tool to approximate the urethra into
a
position to treat the incontinence; and fixing the urethra in the position to
treat
incontinence.
BRIEF DESCRIPTION OF THE FIGURES
Figures 1A, 1B, 1C, and ID illustrate exemplary features of implants,
support portion pieces, and tissue support portions of implants as described.
Figures 2A, 2B, and 2C illustrate exemplary features of implants and tissue
=
support portions of implants as described.
Figures 3A, 3B, and 3C illustrate exemplary features of systems, implants,
and adjustable connections, as described.
Figures 4A, 4D, and 4E illustrates exemplary features of systems, implants,
adjustable connections, pieces of multi-piece implants, and adjusting tools,
as
described.
Figures 4B, 4C, and 4F illustrate exemplary features of embodiments of
adjusting tools, as described.
Figures 5A, 5B, 5C, and 5D illustrate features of exemplary methods of
treating incontinence, as described, and related anatomy.
Figures 6A and 6B illustrate exemplary features of embodiments of adjusting
tools, as described.
Figure 7 illustrates features of exemplary methods of treating incontinence in
a patient, as described, and related anatomy
5

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
Figures 8 and 9 illustrate exemplary features of systems, implants, support
portion pieces, and small-diameter insertion tools, as described.
Figures 10A, 10B, 11A, and 11B illustrate features exemplary small-
diameter insertion tools, as described.
Figures 12A, 12B, and 13 illustrate features exemplary urethra-positioning
tools, as described.
DETAILED DESCRIPTION
The present invention is directed to surgical instruments, assemblies, and
implantable articles for treating urinary incontinence in a male or female,
including
stress urinary incontinence (SUI), as well as related methods Described are
various
features of surgical implants, surgical tools, surgical systems, surgical
kits, and
surgical methods, useful for installing implants for treating incontinence. An

implant can be implanted in a male or a female to treat a condition such as
urge
incontinence, mixed incontinence, overflow incontinence, functional
incontinence,
and the like.
An implant can include a tissue support portion (or "support portion") that
can be used to support a urethra. Supporting a "urethra" refers to supporting
tissue
that includes the urethra (which can refer to the bladder neck) and that can
optionally include tissue adjacent to a urethra such as bulbospongiosus
muscle,
corpus spongiosum, or both. According to various methods, for example, a
support
portion of an implant may either be placed below bulbospongiosus muscle to
support both bulbospongiosus muscle and corpus spongiosum (along with the
urethra), or alternately bulbospongiosus muscle may be dissected and a support

portion of an implant may be placed to contact corpus spongiosum tissue (to
support
the urethra). During use, the tissue support portion is typically placed below
the
urethra, e.g., in contact with corpus spongiosum tissue, and can optionally be

attached to tissue, such as with a suture.
An implant can additionally include one or more extension portion
(otherwise known as "end" portions or "arms") attached to the tissue support
portion. Normally, for treating incontinence, an implant can include two
opposing
extension portions. Extension portions are elongate pieces of material (e.g.,
mesh,
suture, or biologic material) that extend from the tissue support portion and
either
6

CA 2748894 2017-04-21
are or can be connected to the tissue support portion, and are useful to
attach to anatomical
features or "supportive tissue" in the pelvic region (e.g., using a self-
fixating tip) to thereby
provide support for the tissue support portion and the supported tissue.
Generally for treating
incontinence, two extension portions can extend from the opposite ends of a
tissue support
portion as elongate "ends," "arms," or "extensions," and may attach to
supportive tissue in the
pelvic region by extending through a tissue path to an internal anchoring
point (see, e.g.,
Applicant's copending United States Patent Application serial number
12/223,846, filed August
8,2008, by Ogdahl, entitled SURGICAL ARTICLES AND METHODS FOR TREATING
PELVIC CONDITIONS), or may extend to an external incision, such as through an
obturator
foramen and through an external incision at a groin or inner thigh (see, e.g.,
Applicant's
copending United States Patent Publication Number US 2006/0287571.
In exemplary uses, each extension portion can extend from the location of
attachment to
the tissue support portion, through pelvic tissue, and optionally attached to
supportive tissue
within the pelvic region; optionally the extension portion can also extend to
and through an
external incision. For certain procedures (that do not involve external
incisions) the supportive
tissue can be tissue adjacent to the urethra such as pelvic fascia; tissue
between the urethra and
an obturator foramen such as pelvic fascia; or tissue of an obturator foramen
such as obturator
fascia, obturator internus muscle, obturator membrane, obturator externus
muscle, etc. For
alternate procedures, sometimes referred to as "transobturator"-type
procedures, an extension
portion can be sized to extend from the tissue support portion, through an
obturator foramen, and
to then exit through an external incision in a region of a groin or inner
thigh, adjacent to an
obturator foramen.
An implant may include portions, pieces, or sections that are synthetic or of
biological
material (e.g., porcine, cadaveric, etc.). Extension portions may be, e.g., a
synthetic mesh such as
a polypropylene mesh, a suture, a biodegradable suture, etc. The tissue
support portion may be
synthetic (e.g., a polypropylene mesh) or biologic. Examples of implant
products that may be
similar to those useful according to the present description, include those
sold commercially by
American
7

I .. I
CA 2748894 2017-04-21
Medical Systems, Inc., of Minnetonka MN, under the trade names Apogee and
Perigee for
use in treating pelvic prolapse (including vaginal vault prolapse, cystocele,
enterocele, etc.), and
Sparc , BioarcO, and Monarc for treating urinary incontinence.
An example of a particular type of pelvic implant is the type that includes
supportive
portions including or consisting of a tissue support portion and two opposing
extension portions
extending from the tissue support portion. An implant that has exactly two
extension portions
can be of the type useful for treating urinary incontinence. The term
"supportive portions" refers
to portions of an implant that function to support tissue after the implant
has been implanted, and
specifically includes extension portions and tissue support portions, and does
not include
optional or appurtenant features of an implant such as a sheath, tissue
fastener, or self-fixating tip
or other type of connector for attaching the implant to an insertion tool.
A preferred sling for placement against a corpus spongiosum for treatment of
urinary
incontinence in a male patient may optionally and preferably include a widened
central support,
for increased contact and frictional engagement with the corpus spongiosum.
According to
.. exemplary embodiments, the sling can be tensioned to approximate corpus
spongiosum
proximally. A widened tissue support portion can provide improved mechanical
and frictional
engagement between the tissue support portion and the corpus spongiosum. A
widened tissue
support portion provides a larger area of contact between the implant and
corpus spongiosum,
and can have a reduced tendency to fold or deform upon tensioning of the
implant. A suture can
be used to attach the tissue support portion to the corpus spongiosum to
further improve the area
of contact and prevent folding, such as at a location on the anterior side of
the tissue support
portion. A suture may also be useful to prevent movement of the tissue support
portion relative
to the corpus spongiosum during or after installation or tensioning. An
implant for treating male
urinary incontinence can optionally and preferably have a widened tissue
support portion, as
discussed, for example, in Assignee's copending United States Patent
Publication Number US
2006/0287571 and United States Patent Number 7,422,557.
8

CA 02748894 2011-07-04
WO 2010/093421 PCT/US2010/000325
Dimensions of a tissue support portion can be dimensions useful to support
urethra tissue for treating incontinence. A tissue support portion can be of
sufficient
length to support and optionally partially surround a urethra or urethra-
supporting
tissue. A width of a tissue support portion may optionally and preferably be
greater
than a width of extension portions and can be sufficiently wide to increase
contact
area and frictional forces between a tissue support portion and a tissue in
contact
with the tissue support portion. Exemplary lengths of a tissue support portion
can be
in the range from 0.5 to 2 inches, such as from 0.75 to 1.5 inches. Exemplary
widths
of a tissue support portion can be in the range from 0.4 or 0.5 to 4
centimeters, such
as from Ito 2.5 or 3 centimeters. (A tissue support portion may be part of a
support
portion piece that includes the tissue support portion and optionally some
amount of
opposing extension portions extending from ends of the tissue support portion
(see,
e.g., figures 1D, 2A, 2B, 3A, and 4A); when considering dimensions of these
implants, the length of the support portion piece may be considered to include
a
length of the tissue support portion and additionally a length of any portion
of the
support portion piece that is considered to be an extension portion.)
Dimensions of extension portions according to the invention can allow the
extension portion to reach between a tissue support portion placed to support
a
urethra (at an end of the extension portion connected to the tissue support
portion)
and, either: a location at which the distal end of the extension portion
attaches to
supportive tissue at or about the pelvic region; or through an obturator
foramen and
to an external incision at a groin or inner thigh, adjacent to the obturator
foramen.
According to certain methods and implants, a distal end of an extension
portion, according to certain embodiments of the invention, can include a self-

fixating tip that can be attached directly to pelvic tissue such as pelvic
muscle,
ligament, or tendon. The length of the extension portion, therefore, can be in
a range
that allows placement of a tissue support portion as desired to support pelvic
tissue,
while the self-fixating tip is installed in pelvic tissue. Exemplary lengths
of an
extension portion for these embodiments, measured for example between a
connection or boundary between the extension portion and the tissue support
portion, and a distal end of the extension portion, can be, e.g., from 0.5 to
2.75
9

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
inches, preferably from 1.0 to 2.25 inches, and the length can optionally and
preferably be adjustable.
As described elsewhere herein, a length of an extension portion can
optionally be fixed (i.e., the extension portion does not include any form of
length-
adjusting mechanism). Alternate embodiments of implants of the invention may
include adjustment or tensioning mechanisms that allow a physician to alter
the
length of an extension portion before, during, or after implantation.
Examples of various exemplary tissue support portion embodiments are
illustrated at figures 1A, 1B, 1C, ID, and figure 8.
As shown at figure IA, implant 2 includes tissue support portion 4 having
ends 6 and 8, anterior and posterior sides 10 and 12, and connects to two
opposing
extension portions 14. Tissue support portion 4 is a mesh, and extension
portions 14
are sutures, which may be absorbable. Extension portions 14 are illustrated to
be
sutures of fixed (non-adjustable) length. Optionally, however, in use, tissue
fasteners or self-fixating tips (not shown) may be loosely or adjustable
attached to
each of extension portions 14 (as illustrated at figure 1D). Implant 2 can be
placed
in a patient to support a urethra midline 16 (a location half-way between ends
6 and
8), and extension portions 14 can be extended to supportive tissue such as at
fascia
or an obturator foramen, or can extend through an obturator foramen and then
through an external incision adjacent to an obturator foramen. Length LlA can
be
any useful length such as a length in the range from 0.5 to 2 inches. Width
W1A
can be any useful width, such as a width in the range from 0.4 to 2.5 inches.
As shown at figure 1B, support portion piece 20 includes tissue support
portion 24 (mesh) having ends 26 and 28 (alternately, the opposing "tabs" 30
could
be considered to be part of an extension portion of the implant). Apertures 32
can be
reinforced apertures or grommets that engage an extension portion piece (not
shown)
of the implant. Apertures or grommets 32 may be "one-way" grommets that allow
movement of an extension portion piece through the aperture in one direction,
or
that frictionally engage an extension portion piece to resist movement in at
least one
direction. Apertures or grommets 32 are shown to be circular, and as such
would
receive a circular or deformable extension portion piece, but may alternately
be of
another shape such as square or rectangular. Length L1B can be any useful
length,

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
such as from 0.5 to 2 inches; Width W1B can be any useful width, such as a
length
in the range from 0.4 to 2.5 inches.
Support portion piece 20 of figure 1C is similar to support portion piece 20
of figure 1B, modified to include apertures or grommets 32 having a reinforced
rectangular perimeter, or "rectangular grommet." Rectangular grommets 32 are
shown to have "vertical" slots extending from front to back of support portion
piece
20, but may also have "horizontal" slots extending from end to end of support
portion piece 20 (see figure 3A.
Figure 1D shows implant 29 that includes tissue support portion 31 (mesh)
(opposing "tabs" 37 could optionally be considered to be part of the tissue
support
portion or as part of an extension portion of the implant). Sutures 33 form
extension
portions. Self-fixating tips 38 are located on sutures 33, and can be moved
along the
lengths of sutures 33 to adjust a distance between self-fixating tips 38 and
tissue
support portion 31 or midline "M." In use, tissue support portion 31 can be
placed
below a male or female urethra to support the urethra for treating urinary
incontinence. Each of self-fixating tips 38 can be passed through a medial
incision
(using an insertion tool) and implanted at tissue between the urethra and the
patient's
opposing obturator foramen (e.g., secured to opposing obturator foramen),
preferably without creating lateral incisions at opposing inner thighs
(adjacent to
each obturator foramen). Once the two self-fixating tips are affixed to
supportive
tissue, distal (or "free") ends 41 of sutures 33 can be pulled medially to
adjust the
placement of tissue support portion 31 and tension of sutures 33. Optionally
(not
illustrated), extension portions (e.g., tabs 37 or a portion thereof) can
include one or
more tissue fastener.
Figure 8 shows implant 130 that includes tissue support portion 132 (mesh)
and two opposing extension portions in the form of sutures 134. Small-diameter

needles 136 are attached (e.g., by knots or other mechanical or adhesive
connection)
at distal ends of each sutures 134.
Implants as described can include a tissue fastener at a distal end or a
distal
portion of an extension portion, which is the end or portion not attached to a
tissue
support portion. (The term "distal" as used herein when referring to an
extension
portion is the end or portion away from a connection to a tissue support
portion.)
11

I I
CA 2748894 2017-04-21
A tissue fastener at a distal end or portion of a an extension portion can be
any of various
types, including: a self-fixating tip that is inserted into soft tissue and
frictionally retained; soft
tissue anchors; biologic adhesive; a soft tissue clamp that can generally
include opposing,
optionally biased, jaws that close to grab tissue; and opposing male and
female connector
elements that engage to secure an end of an extension portion to tissue. (See
International Patent
Application No. PCT/US2007/014120, entitled "Surgical Implants, Tools, and
Methods for
Treating Pelvic Conditions, filed June 15, 2007; United States Patent
Application Serial Number
12/223,846, filed August 8, 2008, entitled SURGICAL ARTICLES AND METHODS FOR
TREATING PELVIC CONDITIONS; United States Patent Application Serial Number
12/669,099, filed January 14, 2010, entitled PELVIC FLOOR TREATMENTS AND
RELATED
TOOLS AND IMPLANTS: and WO 2009/075800.) An implant may also have one or more
extension portion that does not include a tissue fastener, for example if the
distal end is designed
to be secured to tissue by other methods (e.g., suturing), or is intended to
pass through and
obturator foramen and an external incision, in which case the extension
portion may optionally
include a connector, dilator, or dilating connector, which connects to an
elongate tool that can be
used to either push or pull the connector, dilator, or dilating connector
through a tissue path to an
external incision.
A tissue fastener on an extension portion can be placed at and secured within
internal
tissue of the pelvic region to support the implant and urethra that is
supported by the implant. For
example a tissue fastener can be placed at muscle tissue of an obturator
foramen (e.g., obturator
internus muscle, obturator membrane, obturator externus muscle, fascia), or at
tissue located
between a urethra and an obturator foramen, e.g., pelvic fascia.
One embodiment of a tissue fastener is a self-fixating tip. A "self-fixating
tip" in general
can be a structure (sometimes referred to as a soft tissue anchor) connected
at a distal end of an
extension portion (or extension portion piece) that can be implanted into soft
tissue (e.g., muscle,
fascia, ligament, etc.) in a manner that will maintain the position of the
self-fixating tip and
support the attached implant. Exemplary self-fixating tips can also be
designed to engage an end
of an insertion tool (e.g., elongate needle, elongate tube, etc.) so the
insertion tool can be used to
push the self-fixating tip through and into tissue for implantation,
preferably also through a
medial incision to reach the interior of the pelvic region, e.g., at a
location of an obturator
foramen. The insertion tool may engage the self- fixating tip at an internal
channel of the self-
12

I I
CA 2748894 2017-04-21
fixating tip, at an external location such as at an external surface of the
base, at a lateral
extension, or otherwise as desired, optionally in a manner to allow the
insertion tool to push the
self-fixating tip through an incision in a patient and through and into
supportive tissue.
Exemplary self-fixating tips can include one or more lateral extensions that
allow the
self-fixating tip to be inserted into soft tissue and to become effectively
anchored in the tissue. A
lateral extension may be moveable or fixed. The size of the self-fixating tip
and optional lateral
extensions can be useful to penetrate and become anchored into the tissue.
Exemplary self-
fixating tips are described in Assignee's copending international patent
application
PCTUS2007/004015, filed February 16, 2007, titled Surgical Articles and
Methods for Treating
Pelvic Conditions. Other structures may also be useful.
According to exemplary embodiments, a self-fixating tip can have structure
that includes
a base having a proximal base end and a distal base end. The proximal base end
can be
connected (directly or indirectly, such as by a connective suture) to a distal
end of an extension
portion. The base extends from the proximal base end to the distal base end
and can optionally
include an internal channel extending from the proximal base end at least
partially along a length
of the base toward the distal base end. The optional internal channel can be
designed to interact
with (i.e., engage) a distal end of an insertion tool to allow the insertion
tool to be used to place
the self- fixating tip at a location within pelvic tissue of the patient.
Embodiments of self-
fixating tips also include one or more lateral extension extending laterally
(e.g., radially) from
the base, such as from a location between the proximal end and the distal end,
from a location at
the distal base end, or from a location at the proximal base end.
A self-fixating tip can be made out of any useful material, generally
including materials
that can be molded or formed to a desired structure and connected to or
attached to a distal end
of an extension portion of an implant. Useful materials can include plastics
such as polyethylene,
polypropylene, and other thermoplastic or thermoformable materials, as well as
metals, ceramics,
and other types of biocompatible and optionally bioabsorbable or bioresorbable
materials.
Exemplary bioabsorbable materials include, e.g., polyglycolic acid (PGA),
polylactide (PLA),
copolymers of PGA and PLA.
Optionally, an implant can include a tissue fastener at a location of a tissue
support
portion, or at a location along a length of an extension portion. This form of
tissue fastener,
13

I I
CA 2748894 2017-04-21
sometimes referred to as a "tissue fastener" can be in the form of a
reinforced (e.g., by coating,
heat treating, or a reinforcing weave or strip) edge extensions, multiple
layers of mesh and edge
extensions in an extension portion, etc., as described, for example, at
Applicant's copending
United States Patent Number 7,422,557, and Applicant's copending United States
Patent
Publication Numbers US 2006/0195011, US 2006/0195007, and US 2006/0195010.
Other tissue fastener can be structure that is added to a mesh or other type
of tissue
support portion or extension portion to increase friction between the implant
(e.g., tissue support
portion or extension portion) and adjacent tissue, to prevent movement after
placement of the
implant; i.e., to improve short-term or long- term fixation of the extension
portion within tissue.
Examples of tissue fastener include relatively rigid structures such as metal,
plastic, or other
polymeric or non- polymeric structure that may be shaped to frictionally
engage soft tissue, for
example to include a tine, hook, chevron, barb, arrow, etc., combinations
thereof, or any
structure added to an edge or surface of an extension portion to improve
fixation within tissue.
The structure can have any shape or form that will increase frictional force
between the implant
and adjacent tissue, such as one or multiple pointed surface directed along a
length of an
extension portion, toward the tissue support portion, and extending away from
a surface or edge
of the implant (e.g., extension portion). The tissue fastener can be secured
to a surface or edge of
an extension portion by adhesive, thermoforming, insertion into a weave of a
mesh, or any other
fashion that will secure the tissue fastener to increase frictional resistance
between the extension
portion and adjacent tissue.
14

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
The tissue fastener can be located at a position of an implant that will
result
in the tissue fastener being located at supportive tissue such as muscle or
fascia
when the implant is placed with a midline of the tissue support portion being
located
below a urethra. For example, a tissue fastener may be located on a tissue
support
portion or an extension portion of an implant, e.g., as close as 2 or 3
centimeters
from a midline of a tissue support portion, and up to a distance that reaches
tissue of
an obturator foramen when the midline is located below a urethra, e.g., up to
7
centimeter from the midline.
Examples of various exemplary implant embodiments that include tissue
fasteners are illustrated at figures 2A, 2B, and 2C.
As shown at figure 2A, implant 40 includes tissue support portion 42 and
opposing extension portions 44. Tissue support portion 42 and extension
portions
44 are an integral mesh. Tissue fasteners 48 are structures added to the mesh
of
extension portions 44, e.g., by thermoforming a polymeric material (e.g.,
polypropylene) in the illustrated shape, or by other attachment such as by
adhesive
attachment. Tissue fasteners 48 can be relatively rigid, such as of a
polymeric
material (e.g., polypropylene). Tissue fasteners 48 are "chevron"-shaped, with
ends
49 slanted toward midline "M," in a manner to facilitate movement of extension

portion 44 through tissue in one direction (away from midline "M"), and
resulting in
a resistant force against movement in the opposite direction once placed.
Implant 40
can be placed in a patient to support a urethra, above midline "M" (a location
at the
middle of tissue support portion 40), and extension portions 44 can be
extended to
supportive tissue such as at an obturator foramen or tissue or fascia located
between
the urethra and an obturator foramen. The range of distance (length L2A)
between
tissue fasteners 48 and midline "M" can be a useful length, such as a length
in the
range from 3 to 7 centimeters.
Figure 2B shows (top view) an alternate implant 40, having similar features
but alternate versions of tissue fastener 48. Figure 2C is a side view of
figure 2B.
According to various embodiments of implants described herein, an implant
can include multiple pieces that are adjustably connected together by an
adjusting
engagement. A "multi-piece" implant refers to an implant that includes a
"support
portion piece" and one or multiple "extension portion piece" as separate
pieces of

CA 2748894 2017-04-21
the implant. An extension portion piece can be separate from a support portion
piece, and the two
pieces can be connected through an adjustable engagement. The support portion
piece includes a
tissue support portion.
An adjusting engagement may be for example a one-way adjusting engagement or a
two-
.. way adjusting engagement, that allows a portion or a segment of an implant
to be moved relative
to another portion or segment, and adjusted as to length, tension, or
positioning. Examples of
adjusting engagements are described, for example, in Applicant's copending
United States Patent
Application Number 12/308,436, filed December 15, 2008, entitled SURGICAL
IMPLANTS
AND TOOLS FOR TREATING PELVIC CONDITIONS, and United States Patent Application
Number 12/669,099, filed January 14, 2010, entitled PELVIC FLOOR TREATMENTS
AND
RELATED TOOLS AND IMPLANTS. As an example, an extension portion piece can be
attached to a support portion piece at an adjusting engagement to allow
adjustment of a length of
extension portion.
Some adjusting engagements can allow two-way movement of one piece relative to
another piece (e.g., a "two-way" adjusting engagement). This type of adjusting
engagement
allows movement of a segment of implant (e.g., of a segment or portion of an
extension portion
piece) in two directions through an adjusting engagement. The force needed to
move the segment
of implant in one direction is substantially equal to the force needed to move
the segment in the
opposite direction, and, optionally, the two-way adjusting engagement does not
substantially
hinder the movement of a segment of implant through the adjusting engagement
with frictional
surfaces such as extensions (e.g., "teeth") extending into an aperture through
which the segment
of implant is moved. As an example, a two-way adjusting engagement may include
an open
(smooth) aperture that may be circular, oval, square, elongate, or
rectangular, such as in the form
of a circle, slit, or slot, etc. The aperture may optionally be reinforced by
a reinforced perimeter
of a shape that is similar to the aperture, such as by a fabric or a polymeric
material such as a
grommet (e.g., a "loose grommet" or "eyelet"), which may be circular, square,
rectangular, or of
any desired shape. The reinforced perimeter (e.g., grommet)
16

CA 02748894 2011-07-04
WO 2010/093421 PCT/US2010/000325
defines a reinforced aperture through which a segment of implant can pass
relatively
freely and with the same resistance two different directions.
Other adjusting engagements may allow for one-way adjustment such as
shortening of a length of an extension portion. These adjusting engagements
can be
referred to as "one-way" adjusting engagements, and allow adjustment of a
length of
an implant portion (e.g., extension portion) in one direction and not (or not
easily) in
an opposite direction. An exemplary one-way adjusting engagement can include
an
aperture through which a segment of implant (e.g., a portion of an extension
portion
piece) can extend, and one or multiple surfaces (e.g., extensions or teeth)
that
frictionally engage the segment of implant passing therethrough, e.g., by
extending
into or toward the aperture or otherwise contacting the segment of implant to
inhibit
movement of the segment of implant relative to the adjusting engagement. The
one-
way engagement can preferentially allow movement of the segment of implant
through the aperture in one direction while inhibiting or preventing movement
of the
segment of implant in an opposing direction.
In use of a tissue support portion that includes a one-way adjusting
engagement such as a round or rectangular grommet, a tissue fastener (e.g., a
self-
fixating tip) at one end of an extension portion is placed at tissue as
desired, and the
second (loose) end of the extension portion piece is passed through the one-
way
adjusting engagement. The engagement is adjusted to place the support portion
piece at a desired position (length) of the extension portion piece to provide
desired
support to a urethra. The one-way adjusting engagement moves easily along the
extension portion piece in a direction that tightens the implant against
urethra tissue,
and does not move easily in the opposite direction. Once placed in position
below
the urethra and tightened as desired, the support portion piece is prevented
from
moving along the extension portion piece in the direction to reduce support of
the
urethra. The extension portion piece may optionally be smooth, without any
frictional surface, or may alternately include bumps, detents, teeth, a jagged
surface,
or other frictional or mechanical structure to engage opposing structure at a
surface
of an aperture of the one-way adjusting engagement.
In other embodiments, an extension portion piece may engage a support
portion piece at a two-way adjusting engagement, and another adjusting
engagement
17

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
(e.g., a one-way adjusting engagement) can be used to secure final positioning
of the
two pieces. As an example, a segment of an extension portion piece may extend
through a two-way adjusting engagement located at a support portion piece.
Because the two-way adjusting engagement allows adjustment in two directions,
a
second adjusting element can be used to fix the extension portion piece in
place
relative to the support portion piece. For example, an adjusting engagement in
the
form of a one-way grommet can be placed on the loose end of the extension
portion
piece. The one-way grommet can be used to secure the positioning of the
extension
portion piece and support portion piece after adjustment.
In use, the tissue fastener (e.g., a self-fixating tip) located, e.g., on an
extension portion, is placed at tissue as desired, and the second (loose) end
of the
extension portion piece is passed through the two-way adjusting engagement.
The
engagement is adjusted to place the support portion piece at a desired
position
(length) of the extension portion piece. A second adjusting engagement, e.g.,
a one-
way grommet, is slid onto the loose end of the extension portion piece and
slid along
the extension portion piece to a location at the two-way adjusting engagement.
The
one-way adjusting engagement moves easily along the extension portion piece in
the
direction toward two-way adjusting engagement, and does not move easily in the

opposite direction. Once placed in position near the two-way adjusting
engagement
of the support portion piece, the support portion piece is prevented from
moving
along the extension portion piece in the direction of the one-way adjusting
engagement.
An example of a multi-piece implant is shown at figure 3. Kit or assembly
60 includes support portion piece 62 and two extension portion pieces 64.
Support
portion piece 62 includes tissue support portion 66 and may optionally include
or be
considered to include an amount of an extension portion. Grommets 68 may be
one-
way grommets or two-way grommets, and are illustrated to be rectangular, to
accommodate extension portion pieces 64, also of rectangular cross section.
Grommets 68 are illustrated as "two-way" grommets with frictional surfaces;
the
adjusting engagement is frictional and opposes movement in either direction,
but
opposes movement in each direction by the same amount and does not prevent
movement in either direction. Aperture 76 is rectangular, is sized to allow
passage
18

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
of extension portion piece 64, and includes extension 74 (see figures 3B and
3C),
which extends into aperture 76 to frictionally engage surfaces of extension
portion
piece 64. Distal ends of extension portion pieces 64 include self-fixating
tips 70 for
placement at soft supportive tissue such as fascia, muscle, or other tissue of
a pelvic
region or an obturator foramen. Extension portion pieces 64 are elongate, non-
mesh,
plastic strips having any cross sectional shape or form (rectangular, as
illustrated),
and having frictional engagements 72 along a length, in the form of lateral
ridges,
teeth, or jagged edges, that frictionally interact with extension 74 of
rectangular
grommet 68. Figure 3B shows a detailed illustration of rectangular grommet 76
and
extension 74 into aperture 76. Figure 3C shows extension portion piece 64
placed
within aperture 76, with frictional engagement between engagements 72 of
extension portion piece 64, and grommet extension 74.
Another example of a multi-piece implant is shown at figure 4. Kit or
assembly 80 includes support portion piece 82 and two extension portion pieces
84.
Support portion piece 82 includes tissue support portion 86 and may optionally
include or be considered to include an amount of an extension portion.
Grommets
88 are illustrated to be two-way grommets (but may alternately be one-way
grommets) and are illustrated to be round (e.g., circular), to accommodate the
round
(e.g., circular) non-mesh portion 85 of extension portion pieces 84. Aperture
86 is
round, is sized to allow passage of extension portion piece 84, and as
illustrated is a
two-way grommet. Distal ends of extension portion pieces 84 include self-
fixating
tips 90 for placement at soft supportive tissue such as fascia, muscle, or
other tissue
of a pelvic region or an obturator foramen. Extension portion pieces 84 are
elongate
strips that include mesh portion 87 and non-mesh portion 85 in the form of a
plastic
"rod" having a round (e.g., circular) cross section. As illustrated, non-mesh
portions
85 are relatively smooth and do not include frictional engagements to
frictionally
interact with grommet 88.
Figure 4 also illustrate adjusting tool 92 as an optional component of kit 80.

Embodiments of the invention that include multi-piece implants can involve an
adjusting tool for simultaneously contacting two surfaces of an implant,
especially
two spaced surfaces of a support portion piece, to manipulate or stabilize the
support
portion piece, to allow adjustment of extension portion pieces relative to the
support
19

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
portion piece. Preferred tools can include two adjusting surfaces that are
capable of
concurrently (e.g., simultaneously) contacting two spaced surfaces of a
support
portion piece, each of the two surfaces of the support portion piece being
part of, at,
or adjacent to a component of an adjustable connection, such as at or proximal
to a
surface of a grommet.
An adjusting tool can include any useful structure to support the adjusting
surfaces of the adjusting tool, such as a handle (optional) at a proximal end,
a shaft
extending from the handle, or alternate forms of support for the adjusting
surfaces.
An adjusting surface can be any surface that can contact or otherwise engage a
surface of an implant. Optionally and preferably an adjusting surface can be a
structure that defines an aperture, slot, or slit, that is sized to engage an
extension
portion piece (e.g., a proximal end of an extension portion piece) by
threading or
otherwise passing the extension portion piece through the aperture, slot, or
slit, to
guide or otherwise engage the extension portion piece during adjustment.
Adjusting
surfaces of an adjusting tool can be spaced from each other by a distance that
will
allow simultaneous contact with two locations on opposing sides of an implant
(e.g.,
at opposite ends of a tissue support portion) during use of the adjusting tool
to adjust
the placement of the implant relative to extension portion pieces and relative
to
urethral tissue being supported. For example, adjusting surfaces may be
located on a
line that is perpendicular to an axis of a shaft of an adjusting tool, or that
is
perpendicular to a line parallel to an axis of a shaft of a tool, and may be
spaced by a
distance in the range of 0.5 to 6 centimeters, such as a distance in the range
from 2
to 5 centimeters.
In certain embodiments, each of two adjusting surfaces can be located at an
end of a single or of two shafts extending from a handle. In particular
embodiments
a single shaft may extend from a handle, two separate tines or extensions can
extend
in different directions from the single shaft, and one adjusting surface can
be at an
end of each tine (or "extension"). For example, an adjusting tool may include
a
handle, a single shaft, and a "yoke" fixed or movably located at a distal end
of the
shaft; the yoke can extend in two directions from the shaft and can include
one
adjusting surface at the end of each extension. A line that connects the
adjusting
surfaces may be located to intersect a longitudinal axis of the shaft (the
shaft, shaft

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
extensions, and adjusting surfaces are contained in a single plane), or, in
alternate
embodiments, a line that connects the adjusting surfaces may be located to not

intersect a longitudinal axis of the shaft (the shaft, shaft extensions, and
adjusting
surfaces are not contained in a single plane).
The adjusting surfaces can optionally be fixed or may be moveable, e.g.,
relative to a shaft. The adjusting surfaces may be fixed, or may be capable of
being
moved relative to a shaft in a manner to allow the adjusting surfaces to
contact and
adjust an implant by contacting opposite ends of the implant (e.g., support
portion
piece) simultaneously. For example, the adjusting tool may include a handle, a
single shaft, and a "yoke" that can be moved along a length of the shaft, the
yoke
extending in two directions from the shaft and including one adjusting surface
at the
end of each extension. In one embodiment, the yoke may include a central
aperture
at a middle or median location between the adjusting surfaces, and the central

aperture can engage the shaft to allow movement between the yoke and the
shaft.
Other embodiments can allow for movement with alternate structures. The yoke
may be straight or curved.
The distal end of the shaft may optionally be adapted to contact the urethra
during adjustment, for example by having a curved (e.g., concave) surface that

approximates or matches the shape of surface of urethra tissue supported by
the
tissue support portion of the implant being adjusted.
Referring to adjusting tool 92 at figure 4A, a top view, tool 92 includes
handle 94, shaft 96 extending from a proximal shaft end at handle 94, to
junction 95,
where the distal end of shaft 96 meets yoke (alternately opposing "yoke
extensions")
98, extending in two directions away from shaft 96. Yoke 98 includes opening
(or
"gap") 104 between its opposing extensions that allows yoke 98 to be placed
below
a urethra with opposing yoke extensions along opposite sides of the urethra,
i.e., to
straddle the urethra. Each of the two distal ends of each yoke extension 98
includes
adjusting surface 102 that surrounds aperture 100, and that can contact a
surface of
an implant such as a grommet, a mesh surface, mesh adjacent to a grommet, or
another surface that is part of an adjusting mechanism or that is adjacent to
an
adjusting mechanism.
21

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
Figures 4B, 4C, and 4F illustrate a top view, side view, and side perspective
view, respectively, of adjusting tool 92. Figure 4F additionally shows
adjusting
surfaces 102 simultaneously engaging two spaced-apart surfaces (81) of support

portion piece 82, each surface at a different end of support portion piece 82,
to adjust
a position of support portion piece 82 relative to non-mesh portions 85.
Figure 4D shows a variation of extension portion piece 84, this variation
including tissue fasteners in the form of "side-barbs" located at edges of
mesh
portion87.
Figure 4E shows a variation of support portion piece 82, this variation
including multiple grommets 88 a opposing ends of support portion piece 82, to
allow for placement of extension portion pieces at different locations of
support
portion piece 82, e.g., to accommodate different sizes or anatomical features
of a
patient.
Figures 5A and 5B show anatomy related to the use of a multi-piece implant
such as implant shown at figure 4A, for treating urethral incontinence in a
male
patient. Medial (perinea]) incision 78 allows access to tissue below a urethra
(110),
such as a bulbar urethra (as described, optionally after dissecting through
bulbospongiosus muscle to reach corpus spongiosum tissue). Distinct from
certain
procedures referred to as "transobturator" methods, no lateral incisions are
required
at left and right inner thigh positions, adjacent to the patient's opposing
left and right
obturator foramen.
Still referring to figures 5A and 5B, one or two insertion tools, e.g., having
a
curved or helical needle portion, are used to place a tissue fastener or self-
fixating
tip (90) at tissue of an obturator foramen (106, e.g., muscle). Each tissue
fastener 90
is at a distal end of an extension portion piece (84) of an implant, and a
tissue
support portion (82) can be placed onto the extension portion pieces, then
moved
and adjusted toward urethra 110 to support the urethra to improve continence.
As further illustrated at figures 5C and 5D, non-mesh portions 85 of each
extension portion piece 84 are threaded through an aperture of grommet (or
other
adjusting engagement) 85. Before or after these placements, self-fixating tips
90 are
placed at supportive tissue, such as opposing obturator foramen 106 (as
illustrated),
alternately at adjacent fascia or at fascia more proximal to urethra 110.
Support
22

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
portion piece 82 is placed below urethra 110 (shown with bladder 108). After
initial
placement, the position of support portion piece 82 relative to urethra 110,
and
relative to extension portion pieces 84, can be adjusted as follows. Proximal
ends of
non-mesh portions 85 are passed through each of two apertures 100; adjusting
tool
92 and support portion piece 82 are moved toward the patient, to move to
support
portion piece 82 into position to support the urethra (see figure 5B). For
final
adjustment, adjusting surfaces 102 of yoke 98 can be moved to contact support
portion piece 82, e.g., at opposed ends of a tissue support portion, e.g.,
adjacent to
grommets 88; further movement of adjusting tool 92 in the direction of bladder
108
causes mesh portion 87 of each extension portion piece 84 to pass into
grommets 88
and become tensioned to support support portion piece 82 and urethra 110. If
necessary to achieve desired adjustment and tension, yoke 98 can be moved to
place
opposing extensions in positions lateral to urethra 110. Adjusting surfaces
102 are
able to contact both of grommets 88 at once, simultaneously, to allow support
portion piece 82 to be advanced uniformly at both ends of a tissue support
portion,
and uniformly relative to both sides of a patient and a urethra.
Another embodiment of an adjusting tool is shown at figure 6A. Adjusting
tool 112 includes handle 114 (which is optional), shaft 116 extending
longitudinally
from a proximal shaft end at handle 114 to distal shaft end 115. Yoke
(alternately
two yoke extensions) 118 extends in two directions (laterally) away from shaft
116.
Yoke 118 includes apertures 120 at ends of opposing extensions 118, and
adjusting
surface 122 that surrounds each aperture 120. Yoke 118 also includes central
aperture 119 (in dashed lines), which fits over shaft 116, allowing yoke 118
to move
(as indicated by arrows) longitudinally along a length of shaft 116. Distal
shaft end
115 includes a concave, curved surface that can be placed against urethra or
associated tissue to allow tool 112 to be used to: 1) adjust a position of a
urethra
(approximate the urethra) by placing distal shaft end 115 in contact with
urethra or
associated tissue; and 2) during the same procedure, using yoke 118 optionally
by
moving yoke 118 longitudinally (e.g., distally) along a length of shaft 116,
to place
adjusting surfaces 122 to contact two different and spaced-apart surfaces of
an
extension portion piece (e.g., opposite ends of a tissue support portion)
simultaneously and adjust a position of the extension portion piece (or tissue
support
23

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
portion) relative to a urethra and relative to extension portions or extension
portion
pieces.
In use as illustrated at figure 7, a portion of an extension portion (e.g.,
proximal non-mesh portion 85 of extension portion piece 84, as illustrated) is
threaded through an aperture of grommet (or other adjusting engagement) 85.
Before or after these placements, self-fixating tips 90 are placed at
supportive tissue
such as opposing obturator foramen 106 (alternately at fascia). Support
portion
piece 82 is placed below urethra 110. After initial placement, the position of
support
portion piece 82 relative to urethra 110, and relative to extension portion
pieces 84,
can be adjusted as follows. Proximal ends of non-mesh portions 85 are passed
through each of two apertures 120 of moveably yoke 118 of adjusting tool 112.
Adjusting tool 112 and support portion piece 82 are moved toward the patient,
e.g.,
by movement of yoke 118, adjusting tool 112, or both, to move support portion
piece 82 into position to support urethra 110. Distal shaft end 115 of shaft
116 can
be used to support or approximate urethra 110 and support portion piece 82.
Thus, a
step of the method can include approximating urethra 110 by supporting urethra
110
(optionally through support portion piece 82) using distal shaft end 115 of
adjusting
tool 112, such as by contacting distal shaft end 115 with urethra 110
(optionally
through support portion piece 82) to temporarily support or approximate
urethra 110
while positioning and adjusting the position of the implant. For final
adjustment,
adjusting surfaces 122 of yoke 118 can be moved longitudinally (proximally or
distally) along a length of shaft 116 to contact support portion piece 82,
e.g., at or
adjacent to grommets 88 (not shown), and movement of yoke 118 distally in the
direction of bladder 108 can cause a mesh portion 87 of each extension portion
piece
84 to pass into grommet 88 and become tensioned to support support portion
piece
82 and urethra 110. Adjusting surfaces 102 are able to contact both of
grommets 88
at once, simultaneously, to allow support portion piece 82 to be advanced
uniformly
on both ends, and uniformly relative to both sides of a patient and a urethra.
Examples of another embodiment of an adjusting tool is illustrated at figure
6B. Adjusting tool 92, a top view, includes handle 94, two shafts 96 each
extending
from a proximal shaft end at handle 94. Each distal end of shafts 96 includes
adjusting surface 102 that surrounds aperture 100.
24

I I
CA 2748894 2017-04-21
Implants as described may be placed to support a urethra of a male or a female
patient, by
methods that involve two opposing transobturator tissue paths, as described a
Applicant's United
States Patent Number 7,070,556 and Applicant's copending United States Patent
Publication
Number US 2006-0287571-Al. These "transobturator" methods generally involve
making two
lateral incisions at the inner thigh, each near a patient's obturator foramen,
and a third, medial
incision at the perineum of a male patient and at vaginal tissue of a female
patient. An implant
(as described herein) is implanted between the medial incision and the two
lateral incisions, with
opposing extension portions of the implant traversing each obturator foramen.
The urethral implant may be placed using one or more tools by installing
extension
portions of the sling between the medial and the lateral incisions and passing
through the
obturator foramen. The extension portion may be passed through the tissue path
by initially
inserting an insertion tool (needle) at a medial incision and advancing the
insertion tool toward
an obturator foramen or through an obturator foramen and to an exit point at a
lateral incision
(this method may sometimes be referred to as an "inside-out" tissue path
trajectory, because the
insertion path of the insertion tool is from the medial incision to the
obturator foramen or to the
lateral incision). Alternately, an extension portion may be placed by
initially placing an insertion
tool through an external, medial incision; advancing the insertion tool
medially through an
obturator foramen and to a medial incision; connecting the insertion tool to
an end of an
extension portion; and retracting the insertion tool to pull the extension
portion into place in the
transobturator tissue path (this method may sometimes referred to as an
"outside-in" tissue path
trajectory, because the insertion path of the insertion tool is from the
lateral incision to a medial
incision).
In more detail, an exemplary method includes steps of creating a medial
incision at the
exterior perineum (in a male), creating an external lateral incision
substantially adjacent the
patient's obturator foramen, providing an elongate surgical instrument such as
an instrument that
comprises first and second regions, the instrument having substantial
structure in two or three
dimensions, and providing an implant for treating the incontinence (a urethral
sling). The two- or
three-

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
= dimensional needle may be passed between the incisions, and then the
implant can
be associated with the instrument, e.g., at the end of the two- or three-
dimensional
region. For example, the needle may be passed from the lateral incision
through the
obturator foramen and to the medial incision, and the implant can be
associated with
the tip of the needle extending from the medial incision. The needle can then
be
pulled back through the incisions to pull the extension portion of the implant
from
the medial incision, through the obturator foramen, and to the lateral
incision.
Alternately, the implant can be associated with the needle before passing the
needle
between incisions. The needle, with the extension portion of an implant
associated
with the needle tip, may then be passed between incisions, such as from the
medial
incision, through the obturator foramen, and then through the lateral
incision. This
can be done on both the right side and the left side of the patient.
According to certain preferred methods of treating incontinence in a male,
using implants as described, an implant can be placed below a urethra to
contact
tissue of a corpus spongiosum (by dissecting bulbospongiosus muscle), and the
urethra can be approximated to improve continence without requiring the
urethra to
be compressed.
As described more specifically in US 2006-0287571-Al, according to
exemplary embodiments of treating incontinence using any of the implants or
tools
described herein, a tissue support portion of an implant can be placed in a
position to
approximate and support a urethra, optionally and preferably without placing
compressive forces on the urethra, to effect improved continence (e.g., in a
male
patient). Preferably, a tissue support portion can be placed to contact tissue
of a
corpus spongiosum and is tensioned to cause approximation of the corpus
spongiosum and urethra in a proximal direction (meaning in this instance,
toward a
bladder). Accordingly, embodiments of the invention generally, in a male
patient,
can relate to placement of a tissue support portion at a location that
supports and is
tensioned to proximally (toward a bladder) re-position a urethra. The implant
can be
tensioned to cause the urethra -- especially the posterior portion of urethra
above a
perineal membrane -- to be moved from an abnormal (e.g., prolapsed or
descended)
position to a position of normal healthy urethral tissue capable of being
fully coapted
upon contraction of the rhabdosphincter. Alternate methods can cause
compression
26

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
of the urethra, but compression is not required in methods that result in
approximation of the urethra to improve continence.
According to these embodiments, a method of surgically installing a urethral
implant can include providing a medial incision at the perineum of a male
patient to
expose bulbospongiosus muscle, optionally and preferably dissecting through
bulbospongiosus muscle to expose corpus spongiosum, and placing a tissue
support
portion of the implant to contact the corpus spongiosum tissue. Optionally the
tissue
support portion can be fixed to the corpus spongiosum, such as by use of a
medical
attachment in the form of a suture, staple, adhesive, or the like. The implant
can be
adjusted, tensioned, etc., e.g. based on the use of an adjusting engagement,
an
adjustment tool, or both, to approximate the urethra to improve continence,
and
tension can optionally and preferably maintained chronically.
In alternate implantation methods in a male or female patient (still
optionally
and preferably in a male patient, placing a tissue support portion in contact
with
corpus spongiosum, and approximating a urethra without a requirement for
compression of a urethra), an implant can be inserted through a medial
(perineal or
vaginal) incision and an extension portion of the implant can be attached to
tissue of
an obturator foramen, or to tissue (e.g., fascia) that lies between a urethra
and tissue
of an obturator foramen. According to such methods, a tissue fastener such as
a self-
fixating tip at a distal end or distal portion of an extension portion can be
engaged at
a distal end of an insertion tool (e.g. a curved elongate needle). The
insertion tool
can be used to place the tissue fastener and extension portion through a
medial
incision (of a male or female patient) and extend the tissue fastener and
extension
portion in a direction of an obturator foramen, e.g., to tissue of the
obturator foramen
or to tissue between a urethra and an obturator foramen. Features of the
inventive
methods, implants, and tools that are described herein can be incorporated
into such
a technique, such as placement of the urethral sling below a urethra at a
tissue of a
bulbospongiosus muscle or a corpus spongiosum, approximation of the urethra to

improve continence (without the need for compression of the urethra), etc.,
use of an
implant that includes adjustable engagements (and steps of adjusting the
implant),
use of an adjustment tool. This method avoids the need for lateral incisions
at the
inner thigh and adjacent to each opposing obturator foramen.
27

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
Embodiments of a transobturator method, e.g., in a male patient, can involve
insertion needles that pass between a lateral incision and medial incision
using a
small-diameter needle. An example of an implant for use in this type method is

shown at figure 8, showing implant 130 that includes tissue support portion
132
- 5 (e.g., having dimensions as described herein), extension portions 134
(sutures as
illustrated, and having dimensions as described herein), and small-diameter
needles
136. Each small-diameter needle can be of a shape as described to be useful or

desired for passing an extension portion of an implant through a
transobturator tissue
path extending between a lateral incision and a medial incision. The shape may
be
straight, two dimensionally curved, or three dimensionally curved (e.g.,
helical).
According to the present description, one or more needle for placing an
extension portion at a transobturator tissue path, along some or a portion of
a length
of the needle, may be of a "small-diameter," e.g., less than 0.09 inch in
diameter,
preferably less than 0.07 or 0.06 inch in diameter. A small-diameter needle
can
reduce trauma to tissue, increasing patient comfort and possibly improving
cure and
recovery rates. The needle may be of a small-diameter along an entire length
of the
needle, or may be of a small-diameter (as described) at a portion of a leading
end of
the needle, expanding to a larger diameter at a trailing end of the needle.
For
example the needle may have a small-diameter, e.g., less than 0.09 inch in
diameter,
preferably less than 0.07 or 0.06 inch in diameter, along at least one half of
its entire
length, or along at least three-quarters of its entire length, or along ninety
percent of
its entire length, or along an entire length between a proximal end and a
distal end.
Also, a leading end of the needle can include a tip that is sufficiently sharp
to
penetrate tissue; such a tip at a leading end of the needle can be defined as
a tip that
has a radius of curvature of no greater than 0.015 inch, such as a radius of
curvature
that is no greater than 0.010 inch. Still additionally, the small-diameter
needle can
preferably be of a length (including curvature, meaning an arc-length of a
curved
needle) that allows the needle to extend completely between the lateral
incision and
the medial incision: a leading end of the needle can preferably be extended
from the
lateral incision or the medial incision, while the trailing end has not yet
entered the
medial or the lateral incision (respectively). An exemplary length to allow
the
needle to extend completely between the incisions is a length of at least 4
inches,
28

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
such as a length in the range from about 3 to about 6 inches (see length "L"
of
figures 8 and 9).
A small-diameter needle can optionally include a handle at a proximal
(trailing) end, and can optionally include an aperture or other mechanism to
connect
to an extension portion (e.g., suture) at either a leading end or a:trailing
end.
Insertion tools having small-diameter needles are illustrated at figures 8, 9,

10A, 10B, 11A, and 11B. Figure 10A illustrates a side view of insertion tool
160,
with handle 162 and small-diameter needle 164 having a two-dimensionally
curved
shape. Figure 10B is a front view. Figure 11A illustrates a side view of
insertion
tool 170, with handle 172 and small-diameter needle 174 having a two-
dimensionally curved shape that includes multiple curves in different
directions.
Figure 11B is a front view. Each of the needles (as illustrated) includes a
diameter
that is not uniform but that is greater at the proximal end of the needle
(toward
handle 162, 172) and that decreases moving toward the distal end. Optionally,
the
diameter could be uniform along the entire length between the proximal and
distal
ends. Also optionally, each needle can include an aperture at the distal end,
to attach
a suture.
Figure 8 shows implant 130 that includes tissue support portion 132 (mesh)
and two opposing extension portions in the form of sutures 133. Small-diameter
needles 136 are attached (e.g., by knots or other mechanical or adhesive
connection,
at a proximal end of the needle) at distal ends of each sutures 133. Implant
130 can
be useful for treating urinary incontinence, e.g., in a male, by steps that
include
placing tissue support portion 132 below a urethra or adjacent tissue in a
position to
support the urethra for improving continence, and extending extension portions
134
along transobturator tissue paths. Implant 130 may be placed to support a
urethra,
through a medial incision. Each of the two small-diameter needles 136 can be
inserted into a medial incision and then passed through an obturator foramen
and to
an exit point at a location of an inner thigh, adjacent to the obturator
foramen. The
extension portion may be pulled through the tissue path using the small-
diameter
needle, by the connection at the trailing end of needle 136 (using an "inside-
out"
tissue path trajectory). This can be done on the left and the right sides of
the patient.
29

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
Figure 9 shows an alternate embodiment of an implant as part of kit 140,
including small-diameter needles 146. Implant 150 includes tissue support
portion
142 (mesh) and two opposing extension portions in the form of sutures 144.
Small-
diameter needles 146 are attached at a proximal end of each needle to handles
141.
Optionally, and as illustrated, the diameter of each of small-diameter needles
increases toward handles 141. Each distal end 152 includes aperture 143, for
connecting to a suture 144. Kit 140, including implant 150, can be useful for
treating urinary incontinence, e.g., in a male, by steps that include placing
tissue
support portion 142 below a urethra or adjacent tissue in a position to
support the
urethra for improving continence, and extending extension portions 144 along
transobturator tissue paths. Implant 150 may be placed to support a urethra,
through
a medial incision. Each of the two small-diameter needles 146 can be inserted
into a
patient through a skin location at an inner thigh location, adjacent to an
obturator
foramen, and then passed through an obturator foramen and to the medial
incision.
The extension portion (suture 144) may then be attached to distal end 152 of
small-
diameter needle 146, e.g., through aperture 143. Small-diameter needle 146 can

then be retracted back through the tissue path to pull suture 144 into place,
at a
transobturator tissue path (using an "outside-in" tissue path trajectory).
This can be
done on a left and a right sides of the patient.
In other embodiments of methods for treating incontinence in a male or a
female, a method can incorporate the use of a urethra-positioning tool to
position a
urethra at a location of improved continence function, such as by
approximating the
urethra toward a bladder or by alleviating prolapse. After using a urethra-
positioning tool to position the urethra at a location to improve continence,
the
method can involve fixing the urethra in place-by any useful fixation
techniques,
such as by use of an implant (as described herein, or otherwise); by use of
tissue
ingrowth; by use of accelerated tissue ingrowth or scarring based on injection
of a
substance such as a growth factor, scarring agent, or fibrosis-inducing
composition,
to reduce elasticity of tissue supporting the urethra; by use of a biologic
adhesive;
etc. The method may also include adjustment of the location of the urethra
following initial placement at the desired location. Optionally, the urethra-

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
positioning tool can include a lumen for draining a bladder during a period
over
which the tool is installed to allow for fixation of the urethra.
A urethra-positioning tool can be any tool that includes an elongate shaft
that
is sufficiently rigid (rigid, semi-rigid) to be placed into a urethra, through
a meatus,
and that can be used to cause the urethra to take on the form (shape) and
position of
the elongate shaft. The shaft can be, for example, a solid metal or plastic
rod, or
may be in the form of a catheter that includes a drainage lumen. A handle at a

proximal end can facilitate insertion of a distal end into a meatus and
placement of
the urethra-positioning tool within a urethra to position the urethra at a
location of
improved continence function.
The shaft can be of a length to extend from a meatus, through a urethra, and
to a portion of urethra that is prolapsed and that can be adjusted to improve
continence; e.g., a length can be sufficient to extend from a meatus to a
bladder neck
or a bladder, optionally after a prostate and prostatic portion of a urethra
has been
removed, e.g., a length in the range from 11 to 22 centimeters, such as from
14 to 21
centimeters. The shaft can be of a shape that is at least partially curved to
approximate curves of a urethra, optionally including curves of three portions
of the
urethra, including the prostatic urethra, the membranous urethra, and the
cavernous
urethra of the penis i.e., to mimic the shape of a healthy, properly-
anatomically-
supported, continent urethra, or a portion thereof. For example, a distal
portion of
the shaft can be of a curved shape that can mimic a healthy, properly-
anatomically-
supported, continent, membranous or prostatic urethra, and a proximal portion
of the
shaft can be curved to mimic a cavernous portion of the urethra that passes
through a
penis; such a shaft will have a "double curve" that mimics a double curve of a
healthy urethra or of a continent urethra after removal of a prostate and a
portion of
the prostatic urethra.
Figure 12A, 12B show examples of urethra-positioning tools. Figure 12A
and 12B are side view and top-view (respectively) of tool 180, which includes
shaft
182 and handle 184. Distal portion 186 is curved to approximate a shape of a
healthy, well-supported and properly-anatomically-positioned prostate.
Figure 13 shows a side view of urethra-positioning tool 190, which includes
shaft 193, proximal end 192, distal end 198, and drainage lumen 194 (in dashed
31

CA 02748894 2011-07-04
WO 2010/093421
PCT/US2010/000325
lines). Distal portion 196 is curved to approximate a shape of a healthy, well-

supported and properly-anatomically-positioned prostate; a proximal portion is

curved to mimic a cavernous urethra passing, e.g., through a male penis.
For fixing the urethra in place, after desired positioning using a urethra-
positioning tool, examples of useful biologic adhesives include cyanoacrylate,
as
well as other known adhesives useful in biologic applications. Examples of
useful
scarring agents, growth factors, and fibrosis-inducing compositions, to reduce

elasticity of tissue supporting the urethra, can include hydrocarbon (e.g.,
petroleum
jelly) as described at United States Patent Application Publication Number US
2004/0076653. Some exemplary scarring agents include the category of
substances
called "sclerosing agents" which are normally used for sclerotherapy. Examples

include sodium morrhuate, sodium solution, glucose solution, and crushed
pumice.
Any of these materials can be injected into tissue surrounding a urethra, such
as
proximal to urethra submucosa after placing the urethra into a desired
position
using the urethra-positioning tool -- to fix the position of the urethra. The
amount of
time needed to achieve desired fixation can depend on the type of material
injected.
A biological adhesive may be capable of fixing tissue in a short time, such as

minutes, hours, or days. A growth factor or scarring agent may require days or

weeks to achieve fixation, during which time the urethra-positioning tool must
remain in place. Optionally, if a urethra-positioning tool remains in place
over an
extended period, such as many hours, days, or weeks, the tool can include a
drainage
lumen to allow urine to pass.
Methods that do not place an implant during the fixation step can avoid the
use of any incisions, i.e., can be an incision-less method of treating
incontinence.
Alternate methods can involve an incision to place a positioning mechanism
such as an inflatable item (e.g., an inflatable balloon or pillow) below the
urethra, to
adjust the position of the urethra during or after a procedure to position and
fix the
urethra in place. At any time after a procedure of positioning the urethra,
with
implantation of an inflatable balloon or pillow, the size of the inflatable
balloon or
pillow can be changed to adjust the position of the urethra. The size of the
balloon
or pillow may be adjusted, for example, by use of a hypodermic needle to pass
a
fluid through skin, with no incision, into or out of the inflatable item.
32

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 2018-11-13
(86) PCT Filing Date 2010-02-10
(87) PCT Publication Date 2010-08-09
(85) National Entry 2011-07-04
Examination Requested 2015-01-19
(45) Issued 2018-11-13
Deemed Expired 2020-02-10

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $400.00 2011-07-04
Maintenance Fee - Application - New Act 2 2012-02-10 $100.00 2012-01-20
Maintenance Fee - Application - New Act 3 2013-02-11 $100.00 2013-01-23
Maintenance Fee - Application - New Act 4 2014-02-10 $100.00 2014-01-15
Maintenance Fee - Application - New Act 5 2015-02-10 $200.00 2014-12-30
Request for Examination $800.00 2015-01-19
Maintenance Fee - Application - New Act 6 2016-02-10 $200.00 2016-01-07
Maintenance Fee - Application - New Act 7 2017-02-10 $200.00 2017-01-12
Registration of a document - section 124 $100.00 2018-01-05
Registration of a document - section 124 $100.00 2018-01-05
Registration of a document - section 124 $100.00 2018-01-05
Maintenance Fee - Application - New Act 8 2018-02-12 $200.00 2018-01-17
Final Fee $300.00 2018-09-28
Maintenance Fee - Patent - New Act 9 2019-02-11 $200.00 2019-01-16
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BOSTON SCIENTIFIC SCIMED, INC.
Past Owners on Record
AMERICAN MEDICAL SYSTEMS, LLC
AMS RESEARCH CORPORATION
AMS RESEARCH, LLC
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 2011-07-04 2 73
Claims 2011-07-04 6 224
Drawings 2011-07-04 12 268
Description 2011-07-04 32 1,742
Representative Drawing 2011-08-29 1 11
Cover Page 2012-09-07 1 42
Prosecution-Amendment 2011-09-15 1 32
PCT 2011-09-15 12 468
Description 2017-04-21 32 1,615
Claims 2017-04-21 2 50
Examiner Requisition 2017-07-10 3 191
Amendment 2018-01-09 8 274
Description 2018-01-09 33 1,664
Claims 2018-01-09 3 73
Refund 2018-01-26 3 109
Office Letter 2018-04-12 2 66
Final Fee 2018-09-28 2 58
Representative Drawing 2018-10-12 1 12
Cover Page 2018-10-12 1 41
PCT 2011-07-04 7 207
Assignment 2011-07-04 3 103
Fees 2012-01-20 1 39
Fees 2013-01-23 1 39
Fees 2014-01-15 1 41
Fees 2014-12-30 1 39
Maintenance Fee Payment 2016-01-07 1 42
Prosecution-Amendment 2015-01-19 1 41
Examiner Requisition 2016-11-02 3 241
Examiner Requisition 2016-02-08 3 241
Prosecution Correspondence 2016-09-28 3 96
Correspondence 2016-10-18 1 23
Maintenance Fee Payment 2017-01-12 1 40
Amendment 2017-04-21 27 1,449